Subscribe
About us
Advertise with us
NeuroSens
Menu
Skip to content
Home
Neurology
Psychiatry
Topic: MS
No gain with higher dose of glatiramer acetate
August 24, 2011
Oral cladribine discontinued for MS
June 29, 2011
MS incidence higher in African Americans
April 15, 2011
Comorbidities common, delay MS diagnosis
April 15, 2011
Fingolimod: disease-free rates and effect on brain atrophy
April 15, 2011
MS patients may prefer new therapies regardless of risk
April 14, 2011
Alemtuzumab reduces 1-year sustained disability: CAMS223 analysis
April 14, 2011
Natalizumab discontinuation/interruption: relapse risk, poor tolerability
April 13, 2011
3-month disability progression reduced with fingolimod
April 13, 2011
B cell drug set to enter phase III testing
March 30, 2011
Previous
33
34
35
36
37
Next
